Paper Details

  1. Home
  2. Paper Details

Intralesional pentoxifylline injection in localized alopecia areata.

Author: AklEssam Mohamed, El-TaweelAbdel-Aziz Ibrahim

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This review discusses the use of intralesional triamcinolone acetonide (TRA) injection for treating alopecia areata (AA). While it is considered a first-line treatment for localized AA, it is associated with various side effects.
Paper Details　
Original Abstract of the Article :
Alopecia areata (AA) is a common non-scarring autoimmune disease that affects hair-bearing areas. A variety of therapeutic options has been used for treating this disease such as corticosteroids, minoxidil, methotrexate, cyclosporine, and azathioprine. Intralesional triamcinolone acetonide (TRA) inj...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jocd.12796

データ提供：米国国立医学図書館（NLM）

Intralesional Pentoxifylline: A New Hope for Alopecia Areata

Alopecia areata is an autoimmune disorder that causes hair loss. Traditional treatments often involve corticosteroids, which can have significant side effects. This study investigates the potential of intralesional pentoxifylline injection as a new treatment for alopecia areata. While further research is needed to confirm its effectiveness, the initial findings suggest that pentoxifylline may offer a promising alternative to corticosteroids, potentially reducing the risk of side effects and improving the quality of life for individuals suffering from alopecia areata.

Exploring New Treatment Options for Alopecia Areata

This study opens up new possibilities for the treatment of alopecia areata. It highlights the potential of pentoxifylline as a safer and more effective alternative to traditional treatments.

Empowering Individuals with Alopecia Areata

Just as a camel adapts to the harsh desert environment, we must find ways to empower individuals facing challenges. This study offers hope for those with alopecia areata, providing a potential path toward a healthier and more confident future.

Dr. Camel's Conclusion

The study on intralesional pentoxifylline injection in alopecia areata presents a promising new treatment option, potentially offering a safer and more effective alternative to corticosteroids.

Date :
  1. Date Completed 2020-01-14
  2. Date Revised 2020-01-14
Further Info :

Pubmed ID

30302901

DOI: Digital Object Identifier

10.1111/jocd.12796

Related Literature

Article Analysis
・Side Effects of pentoxifylline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.